Effects of chlorophyllin on transport of dibenzo(a,l)pyrene, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine, and aflatoxin B1 across Caco-2 cell monolayers

Toxicology

Volumn 196, Issue 1-2, 2004, Pages 117-125

  Mata, John E ^a   Yu, Zhen ^a   Gray, John E ^a   Williams, David E ^a,b   Rodriguez Proteau, Rosita ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

2 Amino 1 methyl 6 phenylimidazo 4,5 b pyridine (PhIP); Aflatoxin B1 (AFB1); Caco 2 cells; Chlorophyllin (CHL); Dibenzo(a,l)pyrene (DBP); Polycyclic aromatic hydrocarbon (PAH)

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO [4,5 B]PYRIDINE; AFLATOXIN B1; CHLOROPHYLL; DIBENZO[A,L]PYRENE; PYRENE DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ADDITION REACTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BIOAVAILABILITY; CANCER CELL; CELL MEMBRANE PERMEABILITY; CHEMICAL STRUCTURE; CHEMOPROPHYLAXIS; COMPLEX FORMATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REDUCTION;

EID: 1242293748     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2003.11.008     Document Type: Article

References (35)

1. Artursson P., Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175:1991;880-885.
2. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. 46:2001;27-43.
3. Augustsson K., Skog K., Jagerstad M., Steineck G. Assessment of the human exposure to heterocyclic amines. Carcinogenesis. 18:1997;1931-1935.
4. Bailey C.A., Bryla P., Malick A.W. The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv. Drug Deliv. Rev. 22:1996;85-103.
5. Baker S.S., Baker R.D. Jr. Antioxidants enzymes in he differentiated Caco-2 cell line. In Vitro Cell Dev. Biol. 28A:1992;643-647.
6. Boulenc X., Bourrie M., Fabre I., Roque C., Joyeux H., Berger Y., Fabre G. Regulation of cytochrome P450IAI gene expression in a human intestinal cell line, Caco-2. J. Pharmacol. Exp. Ther. 263:1992;1471-1478.
7. Breinholt V., Arbogast D., Loveland P., Pereira C., Dashwood R., Hendricks J., Bailey G. Chlorophyllin chemoprevention in trout initiated by aflatoxin B(1) bath treatment: An evaluation of reduced bioavailability vs. target organ protective mechanisms. Toxicol. Appl. Pharmacol. 158:1999;141-151.
8. Breinholt V., Schimerlik M., Dashwood R., Bailey G. Mechanisms of chlorophyllin anticarcinogenesis against aflatoxin B1: complex formation with the carcinogen. Chem. Res. Toxicol. 8:1995;506-514.
9. Conners, K., 1987. Binding Constants: The Measurement of Molecular Complex Stability. Wiley, New York.
10. Dashwood R., Yamane S., Larsen R. Study of the forces stabilizing complexes between chlorophylls and heterocyclic amine mutagens. Environ. Mol. Mutagen. 27:1996;211-218.
11. Dashwood R. Chlorophylls as anticarcinogens (Review). Int. J. Oncol. 10:1997;721-727.
12. Dashwood R., Negishi T., Hayatsu H., Breinholt V., Hendricks J., Bailey G. Chemopreventive properties of chlorophylls towards aflatoxin B1: a review of the antimutagenicity and anticarcinogenicity data in rainbow trout. Mutat. Res. 399:1998;245-253.
13. Delie F., Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;221-286.
14. Egner P.A., Stansbury K.H., Snyder E.P., Rogers M.E., Hintz P.A., Kensler T.W. Identification and characterization of chlorine(4) ethyl ester in sera of individuals participating in the chlorophyllin chemoprevention trial. Chem. Res. Toxicol. 13:2000;900-906.
15. Egner P.A., Wang J.B., Zhu Y.R., Zhang B.C., Wu Y., Zhang Q.N., Qian G.S., Kuang S.Y., Gange S.J., Jacobson L.P., Helzlsouer K.J., Bailey G.S., Groopman J.D., Kensler T.W. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. U.S.A. 98:2001;14601-14606.
16. Ferruzzi M.G., Failla M.L., Schwartz S.J. Assessment of degradation and intestinal cell uptake of carotenoids and chlorophyll derivatives from spinach puree using an in vitro digestin and Caco-2 human cell model. J. Agric. Food Chem. 49:2001;2082-2089.
17. Ferruzzi M.G., Failla M.L., Schwartz S.J. Sodium copper chlorophyllin: in vitro digestive stability and accumulation by Caco-2 human intestinal cells. J. Agric. Food Chem. 50:2002;2173-2179.
18. Greenwald P. Diet and Cancer. Perspectives of Prevention. Adv. Exp. Med. Biol. 472:1999;1-19.
19. Grés M.-C., Julian B., Bourrié M., Meunier V., Roques C., Berger M., Boulenc X., Berger Y., Fabre G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the partental Caco-2 cell line. Pharm. Res. 15(5):1998;726-733.
20. Hartman P.E., Shankel D.M. Antimutagens and anticarcinogens: a survey of putative interceptor molecules. Environ. Mol. Mutagen. 15:1990;145-182.
21. Hauri H.P., Sander B., Naim H. Induction of lactase biosynthesis in the human intestinal epithelial cell line Caco-2. Eur. J. Biochem. 219:1994;539-546.
22. Hilgendorf C., Spahn-Langguth H., Regårdh C.G., Lipka E., Amidon G.L., Langguth P. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J. Pharm. Sci. 89:2000;63-75.
23. Howell S., Kenny A.J., Turner A.J. A survey of membrane peptidases in two human colonic cell lines, Caco-2 and HT-29. Biochem. J. 284:1992;595-601.
24. Kelloff G.C., Crowell J.A., Steele V.E., Lubet R.A., Lieberman R., Lawrence J.A., Ali I., Viner J.L., Sigman C.C. Progress in Cancer Chemoprevention. Cancer Control. 4:2000;118-127.
25. Kephart J.C. Chlorophyll derivatives - their chemistry, commercial preparation and uses. Econ. Bot. 9:1955;3-38.
26. Nicklin P.L., Irwin W.J., Hassan I.F., Mackay M., Dixon H.B. The transport of acidic amino acids and their analogues across monolayers of human intestinal absorptive (Caco-2) cells in vitro. Biochem. Biophys. Acta. 1269:1995;176-186.
27. Osypiw J.C., Gleeson D., Lobley R.W., Pemberton P.W., McMahon R.F.T. Acid-base transport systems in a polarized human intestinal cell monolayer: Caco-2. Exp. Physiol. 79:1994;723-739.
28. Reddy A.P., Harttig U., Barth M.C., Baird W.M., Schimerlik M., Hendricks J.D., Bailey G.S. Inhibition of dibenzo[a, l]pyrene-induced multi-organ carcinogenesis by dietary chlorophyllin in rainbow trout. Carcinogenesis. 20:1999;1919-1926.
29. Sugiyama C., Nakandakari N., Hayatsu H., Arimoto-Kobayashi S. Preventive effects of chlorophyllin fixed on chitosan towards DNA adduct formation of 3-amino-1-methyl-5H-pyrido [4,3-b]indole in CDF1 mice. Biol. Pharm. Bull. 25:2002;520-522.
30. Tachino N., Guo D., Dashwood W.M., Yamane S., Larsen R., Dashwood R. Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen. Mutat. Res. 308:1994;191-203.
31. +-coupled absorption. Br. J. Pharmacol. 113:1994;1050-1056.
32. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man -fact or myth. Pharm. Res. 14:1997;763-766.
33. Walle U.K., Walle T. Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps. Carcinogenesis. 20:1999;2153-2157.
34. Young R.W., Beregi J.S. Jr. Use of chlorophyllin in the care of geriatric patients. J. Am. Geriatr. Soc. 28:1980;46-47.
35. Yun C.H., Jeong H.G., Jhoun J.W., Guengerich F.P. Non-specific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes. Carcinogenesis. 16:1995;1437-1440.